Xiaohua Chen

1.3k total citations
32 papers, 976 citations indexed

About

Xiaohua Chen is a scholar working on Molecular Biology, Immunology and Genetics. According to data from OpenAlex, Xiaohua Chen has authored 32 papers receiving a total of 976 indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 7 papers in Immunology and 5 papers in Genetics. Recurrent topics in Xiaohua Chen's work include RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (6 papers) and Virus-based gene therapy research (4 papers). Xiaohua Chen is often cited by papers focused on RNA Interference and Gene Delivery (10 papers), Immunotherapy and Immune Responses (6 papers) and Virus-based gene therapy research (4 papers). Xiaohua Chen collaborates with scholars based in China, United States and Macao. Xiaohua Chen's co-authors include Christian Rueckert, Rainer Borriss, Joachim Vater, Jochen Blom, Richard W. Tsien, David Dooley, László Nádasdi, Andrew Palma, José R. Lémos and William F. Hopkins and has published in prestigious journals such as ACS Nano, PLoS ONE and Biomaterials.

In The Last Decade

Xiaohua Chen

32 papers receiving 959 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaohua Chen China 14 661 195 180 91 90 32 976
Barbara Birkaya United States 20 706 1.1× 96 0.5× 88 0.5× 91 1.0× 60 0.7× 34 956
Ye Tao China 19 525 0.8× 201 1.0× 109 0.6× 57 0.6× 20 0.2× 78 1.0k
Duo Wang China 16 1.1k 1.6× 128 0.7× 141 0.8× 83 0.9× 217 2.4× 47 1.6k
Christian Kukat Germany 20 1.6k 2.4× 103 0.5× 206 1.1× 106 1.2× 110 1.2× 28 2.0k
Serena Camerini Italy 23 849 1.3× 90 0.5× 213 1.2× 49 0.5× 111 1.2× 59 1.3k
Benny Björkblom Sweden 17 788 1.2× 335 1.7× 79 0.4× 67 0.7× 172 1.9× 31 1.3k
Yang Zeng China 19 509 0.8× 129 0.7× 168 0.9× 170 1.9× 191 2.1× 62 1.2k
Zhen Xu China 18 847 1.3× 280 1.4× 60 0.3× 126 1.4× 71 0.8× 49 1.4k

Countries citing papers authored by Xiaohua Chen

Since Specialization
Citations

This map shows the geographic impact of Xiaohua Chen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaohua Chen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaohua Chen more than expected).

Fields of papers citing papers by Xiaohua Chen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaohua Chen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaohua Chen. The network helps show where Xiaohua Chen may publish in the future.

Co-authorship network of co-authors of Xiaohua Chen

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaohua Chen. A scholar is included among the top collaborators of Xiaohua Chen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaohua Chen. Xiaohua Chen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chen, Xiaohua, Yueyang Zhang, Bailing Zhou, et al.. (2025). Intestinal Probiotic Lysate Modified Bifunctional Nanoparticle for Efficient Colon Cancer Immunotherapy. Pharmaceutics. 17(2). 139–139. 1 indexed citations
2.
Chen, Xiaohua, Shuai Ming, Yan Gao, et al.. (2025). Efficient cancer immunogenetherapy by tumor cell lysate modified mRNA formulation. Biomaterials. 324. 123466–123466. 1 indexed citations
3.
Lei, Sibei, Yan Gao, Kaiyu Wang, et al.. (2025). An Implantable Double-Layered Spherical Scaffold Depositing Gene and Cell Agents to Facilitate Collaborative Cancer Immunotherapy. ACS Nano. 19(18). 17653–17673. 1 indexed citations
4.
Sharma, Pratibha, et al.. (2024). DDDR-30. ENHANCED CHEMO AND RADIO-SENSITIZATION OF GLIOMAS BY HSP90 INHIBITION WITH JIN-001, A NOVEL BLOOD-BRAIN BARRIER PENETRANT HSP90 INHIBITOR. Neuro-Oncology. 26(Supplement_8). viii132–viii132. 1 indexed citations
5.
Dou, Zhihui, Wei Su, Taotao Zhang, et al.. (2024). Modification of BCLX pre-mRNA splicing has antitumor efficacy alone or in combination with radiotherapy in human glioblastoma cells. Cell Death and Disease. 15(2). 160–160. 8 indexed citations
6.
Sun, Jingya, Zhigao Zhang, Hao Hu, et al.. (2024). Discovery of a Potent, selective and orally bioavailable CDK9 degrader for targeting transcription regulation in Triple-Negative breast cancer. Bioorganic Chemistry. 153. 107876–107876. 3 indexed citations
7.
Ma, Yan, Xiaohua Chen, Ting Ding, et al.. (2023). KAT7 promotes radioresistance through upregulating PI3K/AKT signaling in breast cancer. Journal of Radiation Research. 64(2). 448–456. 10 indexed citations
8.
Zhang, Jin, Sibei Lei, Jieping Wu, et al.. (2023). Targeted siRNA Delivery by Bioinspired Cancer Cell Membrane-Coated Nanoparticles with Enhanced Anti-Cancer Immunity. International Journal of Nanomedicine. Volume 18. 5961–5982. 10 indexed citations
9.
Lei, Sibei, Xiaohua Chen, Yan Gao, et al.. (2022). ALPPL2‐Binding Peptide Facilitates Targeted mRNA Delivery for Efficient Hepatocellular Carcinoma Gene Therapy. Advanced Functional Materials. 32(43). 21 indexed citations
10.
Gao, Yan, Ke Men, Jieping Wu, et al.. (2021). Functionalized DMP-039 Hybrid Nanoparticle as a Novel mRNA Vector for Efficient Cancer Suicide Gene Therapy. International Journal of Nanomedicine. Volume 16. 5211–5232. 35 indexed citations
11.
Zhang, Fangcheng, Renjie Chai, Qiong Xu, et al.. (2020). Deubiquitinase Inhibitor b-AP15 Attenuated LPS-Induced Inflammation via Inhibiting ERK1/2, JNK, and NF-Kappa B. Frontiers in Molecular Biosciences. 7. 49–49. 13 indexed citations
12.
Ding, Wenwu, et al.. (2019). An auto-inducible expression and high cell density fermentation of Beefy Meaty Peptide with Bacillus subtilis. Bioprocess and Biosystems Engineering. 43(4). 701–710. 11 indexed citations
13.
Wang, Jue, Wei Zhao, Huifang Guo, et al.. (2018). AKT isoform-specific expression and activation across cancer lineages. BMC Cancer. 18(1). 742–742. 39 indexed citations
14.
Hou, Nan, Xiaohua Chen, Zhiping Xu, et al.. (2017). High expression of NDRG3 associates with unfavorable overall survival in non-small cell lung cancer. Cancer Biomarkers. 21(2). 461–469. 15 indexed citations
15.
Chen, Xiaohua, Hanyang Hu, Lin He, et al.. (2016). A novel subtype classification and risk of breast cancer by histone modification profiling. Breast Cancer Research and Treatment. 157(2). 267–279. 20 indexed citations
16.
Zhong, Rong, Xiaohua Chen, Xueqin Chen, et al.. (2015). MAD1L1 Arg558His and MAD2L1 Leu84Met interaction with smoking increase the risk of colorectal cancer. Scientific Reports. 5(1). 12202–12202. 24 indexed citations
17.
Chen, Xiaohua, Hua Du, Li Zou, et al.. (2015). The Associations between RNA Splicing Complex Gene SF3A1 Polymorphisms and Colorectal Cancer Risk in a Chinese Population. PLoS ONE. 10(6). e0130377–e0130377. 6 indexed citations
18.
Ding, Zhiyong, Péter Germán, Shanshan Bai, et al.. (2014). Genetic and Pharmacological Strategies to Refunctionalize the von Hippel Lindau R167Q Mutant Protein. Cancer Research. 74(11). 3127–3136. 22 indexed citations
19.
Chen, Xiaohua, Peng Zhao, Fengsheng Chen, Libo Li, & Rongcheng Luo. (2010). Effect and mechanism of 5-aminolevulinic acid-mediated photodynamic therapy in esophageal cancer. Lasers in Medical Science. 26(1). 69–78. 33 indexed citations
20.
Chen, Xiaohua, Hong Shi, Xiaolin Liu, & Bing Su. (2006). The testis-specific apoptosis related gene TTL.6 underwent adaptive evolution in the lineage leading to humans. Gene. 370. 58–63. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026